The clinical usefulness of Enoxacin (ENX, AT-2266), a new oral antibacterial agent, was compared with that of pipemidic acid (PPA) in the treatment of acute infectious diarrhea (bacillary dysentery, Campylobacter enteritis and enteropathogenic and enterotoxigenic E. coli enteritis) by a double-blind method.Daily dosage of ENX and PPA was 600 mg and 2000 mg, respectively. The duration of the treatment was 5 days. Of 242 cases treated, various statistical analyses were carried out in 146 cases,and 96 cases were excluded.Of 146 cases, 73 cases were treated with ENX or PPA respectively. There was no statistical significance between ENX group and PPA group in terms of the background characteristics and MIC distribution against each drug.The results obtained were as follows.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.